www.fdanews.com/articles/196456-fda-creates-coronavirus-treatment-acceleration-program
![IV patient and doctor](https://www.fdanews.com/ext/resources/test/Drug-Images4/IV-blood-patient-nurse-doctor.gif?t=1585694898&width=430)
FDA Creates Coronavirus Treatment Acceleration Program
March 31, 2020
The FDA launched the Coronavirus Treatment Acceleration Program (CTAP), an emergency program for potential COVID-19 therapies.
The agency has deployed staff specifically to reviewing COVID-19 therapies.
The agency is currently monitoring 10 therapies in active trials and 15 others in planning stages.